TrialPath
Recruiting

PAncreatic Disease Cohort of TOuLouse

NCT05824403 · University Hospital, Toulouse
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

About this study
This collection focuses on pathology of the pancreas requiring specific investigations or management for diagnosis or treatment. Pancreatic pathologies can be classified as malignant, potentially malignant or benign tumors. These can be solid or cystic. There is an inflammatory attack on the pancreas, generating acute pancreatitis in the acute period, if the inflammatory manifestations persist, chronic pancreatitis will develop. Some lesions may be at risk of malignancy during their evolution, it is therefore necessary to improve the performance of monitoring and diagnostic tools in order to adapt the management of patients.
Eligibility criteria
Inclusion Criteria: * Patients with inflammatory or cystic exocrine pancreatic pathology * Patient able to read and understand the information leaflet * Patients who have agreed to participate in the study and have signed the free and informed consent * Patients affiliated to a social security system (including AME) Exclusion Criteria: * Patient with pancreatic cancer pathology * Patients with active cancer, whatever the origin * Pregnant or breastfeeding patients * Patients under legal protection, guardianship or trusteeship
Study design
Enrollment target: 300 participants
Age groups: adult, older_adult
Timeline
Starts: 2023-11-28
Estimated completion: 2027-12
Last updated: 2023-12-04
Primary outcomes
  • Diagnostic tools (3 years after the first inclusion)
Sponsor
University Hospital, Toulouse · other
Contacts & investigators
ContactBarbara BOURNET, MD · contact · bournet.b@chu-toulouse.fr · 0561323235
ContactCindy CANIVET · contact · canivet.c@chu-toulouse.fr · 05 61 32 20 48
InvestigatorBarbara BOURNET, MD · principal_investigator, University Hospital, Toulouse
All locations (1)
Rangueil hospitalRecruiting
Toulouse, France
PAncreatic Disease Cohort of TOuLouse · TrialPath